Zhang Yue-Yang, Cao Rui, Wan Qin
Department of Endocrinology and Metabolism, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, China.
Front Endocrinol (Lausanne). 2025 Apr 16;16:1571602. doi: 10.3389/fendo.2025.1571602. eCollection 2025.
Currently, the plasma atherogenic index (AIP) is mainly used to predict atherosclerosis and cardiovascular diseases. Therefore, we aim to investigate the potential association between AIP and type 2 diabetes through a prospective cohort study.
The 4C study, a multicenter prospective cohort investigation, targets the Chinese population and initially enrolled 10,008 participants. Baseline data encompassing lifestyle, metabolic status, and various other factors were collected in 2011. A 10-year follow-up survey was subsequently conducted, ultimately including 9,092 participants. AIP, defined as the logarithmic transformation of the triglycerides to high-density lipoprotein ratio, was divided into quartiles. To explore the potential association between AIP and the risk of type 2 diabetes, Cox regression, restricted cubic spline, receiver operating characteristic curve(ROC), and subgroup analysis were employed.
Over a 10-year follow-up period, 693 new cases of type 2 diabetes were identified. In a fully adjusted model, AIP demonstrated a positive association with type 2 diabetes (HR: 4.40; 95% CI: 3.21, 6.04). Compared to the Q1 group, the risk of type 2 diabetes increased progressively across the Q2, Q3, and Q4 groups, with a significant trend (p-value < 0.05). Restricted cubic spline (RCS) analysis revealed an inverse L-shaped association between AIP and the risk of type 2 diabetes, with a turning point at 0.45. The ROC analysis indicates that incorporating the AIP into the base model enhances its diagnostic performance for type 2 diabetes. Furthermore, similar patterns were observed in the subgroup analyses.
Among the Chinese population, elevated AIP levels are positively correlated with an increased risk of type 2 diabetes, indicating that AIP could potentially serve as a biomarker for assessing the risk of developing type 2 diabetes.
目前,血浆致动脉粥样硬化指数(AIP)主要用于预测动脉粥样硬化和心血管疾病。因此,我们旨在通过一项前瞻性队列研究来探究AIP与2型糖尿病之间的潜在关联。
4C研究是一项针对中国人群的多中心前瞻性队列调查,最初招募了10,008名参与者。2011年收集了包括生活方式、代谢状况及其他各种因素在内的基线数据。随后进行了为期10年的随访调查,最终纳入9,092名参与者。AIP定义为甘油三酯与高密度脂蛋白比值的对数转换值,并分为四分位数。为探究AIP与2型糖尿病风险之间的潜在关联,采用了Cox回归、限制性立方样条、受试者工作特征曲线(ROC)及亚组分析。
在10年的随访期内,共识别出693例2型糖尿病新发病例。在完全调整模型中,AIP与2型糖尿病呈正相关(HR:4.40;95%CI:3.21,6.04)。与Q1组相比,2型糖尿病风险在Q2、Q3和Q4组中逐渐增加,且具有显著趋势(p值<0.05)。限制性立方样条(RCS)分析显示,AIP与2型糖尿病风险呈倒L形关联,转折点为0.45。ROC分析表明,将AIP纳入基础模型可提高其对2型糖尿病的诊断性能。此外,在亚组分析中也观察到类似模式。
在中国人群中,AIP水平升高与2型糖尿病风险增加呈正相关,表明AIP有可能作为评估2型糖尿病发病风险的生物标志物。